Document is current
Any future updates will be listed below
-
Authors
Ahmed, Wisal https://orcid.org/0000-0001-8155-8249
Mochache, Vernon
Stein, Karin
Ndavi, Patrick
Esho, Tammary
Balde, Mamadou Dioulde
Soumah, Anne-Marie
Diriye, Ahmed
Ahmed, Muna Abdi
Petzold, Max
Pallitto, Christina
-
Funding
Funding for this research was provided by:
Government of Norway
UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction
- License Information
-
More Information
Article History
Received: 13 July 2020
Accepted: 18 January 2021
First Online: 1 February 2021
Ethics approval and consent to participate
: Ethical approval for the master protocol (25/07/2019 version 6) has been obtained from the WHO ERC (P151/03/2014). Each study country submitted country-specific protocols to local institutional review boards (IRBs). In Kenya, ethical approval was obtained from the University of Nairobi/Kenyatta National Hospital ERC (P805/09/2019), while in Somalia it was obtained from the Department of Planning, Policy and Strategic Information, Unit of Research (MOHD/DG: 2/11526/2019). The <i>Comite National d’Ethique Pour la Recherche en Sante</i> (CNERS) provided ethical approval in Guinea (105/CNERS/19). Given the illegality of FGM in two countries (Kenya and Guinea), all study participants will provide verbal informed consent. Important protocol amendments will be communicated to WHO and in-country IRBs. Informed consent will be obtained from all study participants. Detailed steps to ensure participant confidentiality before, during and after study are included in study operations manual.
: Not applicable.
: The authors declare that they have no competing interests.
